Cite
HARVARD Citation
Tuchen, M. et al. (2017). Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells. European journal of cancer. pp. 9-21. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tuchen, M. et al. (2017). Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells. European journal of cancer. pp. 9-21. [Online].